0001562180-22-001079.txt : 20220203 0001562180-22-001079.hdr.sgml : 20220203 20220203173214 ACCESSION NUMBER: 0001562180-22-001079 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220203 DATE AS OF CHANGE: 20220203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ordentlich Peter CENTRAL INDEX KEY: 0001594274 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37708 FILM NUMBER: 22589880 MAIL ADDRESS: STREET 1: C/O SYNDAX PHARMACEUTICALS, INC. STREET 2: 400 TOTTEN POND ROAD, SUITE 140 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syndax Pharmaceuticals Inc CENTRAL INDEX KEY: 0001395937 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320162505 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE STREET 2: BUILDING D, FLOOR 3 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-419-1400 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE STREET 2: BUILDING D, FLOOR 3 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-02-01 false 0001395937 Syndax Pharmaceuticals Inc SNDX 0001594274 Ordentlich Peter C/O SYNDAX PHARMACEUTICALS, INC. 35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3 WALTHAM MA 02451 false true false false Chief Scientific Officer Common Stock 2022-01-31 4 J false 1412.00 12.39 A 1412.00 D Common Stock 2022-02-01 4 S false 1412.00 16.65 D 0.00 D Stock Options (Right to buy) 15.79 2022-02-02 4 A false 80000.00 15.79 A 2032-02-02 Common Stock 80000.00 80000.00 D The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 1,412 shares by the Reporting Person on 01/31/2022 pursuant to the Issuer's Employee Stock Purchase Plan. 1/48th of the shares subject to the option shall vest monthly over a four-year period. /s/ Michael A. Metzger, Attorney-in-Fact 2022-02-03